心炎康胶囊治疗急性病毒性心肌炎临床研究

目的观察心炎康胶囊治疗急性病毒性心肌炎(VMC)的临床疗效。方法将118例VMC患者随机分为2组,治疗组61例给予中药心炎康胶囊,每日3次,每次4粒口服。对照组57例给予维生素C片0.2 g,每日3次口服;泛癸利酮20 mg,每日3次口服。2组均治疗3个月,观察治疗前后临床症状和体征、心电图及相关血液生化指标及安全性观测指标的变化。结果2组临床综合疗效比较,治疗组总有效率82.0%,对照组总有效率59.6%,2组比较有显著性差异(P<0.05);期前收缩的疗效比较,治疗组总有效率89.8%,对照组总有效率60.1%,2组比较有显著性差异(P<0.05);心电图改变的疗效比较,2组无显著性差异(P>0.05)。结论心炎康胶囊治疗VMC疗效好,且无毒副作用。

Clinical effect of Xinyankang capsule on viral myocarditis

Objective To observe the clinical effect of Xinyankang capsule on viral myocarditis.Method 118 patients with Xinyankang capsule on viral myocarditis were randomly allocated to treatment group and control group.Patients in control group(n=57) were treated by routine therapy(Vitamin C,200mg,Ubidecarenone,20mg,three times a day).Patients in treatment group(n=61) were treated by Xinyankang capsule,4 pills three times a day.The course in both groups was 3 months.The symptoms,signs and blood analysis were carried on to compare the effects in both groups.Result Improvement of symptoms of electrocardiogram in treatment group was superior to that in control group.The total effective rate in treatment group(82.0%) was higher than that in control group(59.6%,P<0.05).Conclusion Xinyankang capsule showed better effect on treatment of viral myocarditis.